Skip to content
Accessibility help
Search NICE…
Skip to content
Menu
Sign in
Guidance
Standards and indicators
Life sciences
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
About
Home
NICE guidance
Published
Published
Guidance, NICE advice and quality standards
Skip to filters
Skip to results
Published
In consultation
In development
Awaiting development
Topic selection
Filter (1 active)
Skip to results
Filter by title or keyword
Filter
Last updated date
Last updated date
From date
To date
Apply date filters
Area of interest
Area of interest
Antimicrobial prescribing (2)
Type
Type
Guidance (93)
NICE advice (20)
Quality standard (7)
Guidance programme
Guidance programme
Antimicrobial prescribing guidelines (1)
Clinical guidelines (16)
Diagnostics guidance (1)
Highly specialised technologies guidance (1)
Interventional procedures guidance (14)
Medical technologies guidance (6)
NICE guidelines (18)
Public health guidelines (1)
Social care guidelines (1)
Technology appraisal guidance (53)
Advice programme
Advice programme
Evidence summaries (2)
Medtech innovation briefings (18)
Apply filters
Showing 71 to 80 of 120
Sort by
Date
Title
Apply sorting
Last updated date between 1/7/2021 and 31/1/2022
Remove Last updated date between 1/7/2021 and 31/1/2022 filter
Published guidance, NICE advice and quality standards
Title
Reference number
Published
Last updated
Melatonin for treating sleep disorders in adults who are blind
ES38
18 August 2021
18 August 2021
Mexiletine for treating the symptoms of myotonia in non-dystrophic myotonic disorders
TA748
1 December 2021
1 December 2021
Midostaurin for treating advanced systemic mastocytosis
TA728
22 September 2021
22 September 2021
MMprofiler for prognostic risk classification in multiple myeloma
MIB270
10 August 2021
10 August 2021
Mogamulizumab for previously treated mycosis fungoides and Sézary syndrome
TA754
15 December 2021
15 December 2021
Myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome: diagnosis and management
NG206
29 October 2021
29 October 2021
NBTXR-3 for treating advanced soft tissue sarcoma (terminated appraisal)
TA745
10 November 2021
10 November 2021
Nintedanib for treating progressive fibrosing interstitial lung diseases
TA747
17 November 2021
17 November 2021
Nivolumab for adjuvant treatment of resected oesophageal or gastro-oesophageal junction cancer
TA746
17 November 2021
17 November 2021
Nivolumab for advanced non-squamous non-small-cell lung cancer after chemotherapy
TA713
7 July 2021
7 July 2021
Previous page
1
…
6
7
Current page
8
9
10
…
12
Page
8
of
12
Next page
Results per page
10
25
50
All
Back to top